Discover
IMDX
Insight Molecular Diagnostics Inc.
5.00
1 x 4.12
1 x 7.05
bid
ask
+
0.00
0.00%
08:49 AM
| Ytd | -33.33% | |
| 1y | 65.02% |
day range
2.33
52 week range
8.51
| Open | Prev Close | 5.00 | Low | High | Mkt Cap | 134.21M | |||
| Vol | 0.00 | Avg Vol | 334.76K | EPS | -1.19 | P/E | -4.20 | Forward P/E | N/A |
| Beta | 1.76 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 5.54 | 200-d Avg | 5.44 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 32.00K | ||
| Revenues (USD) | 32.00K | ||
| Cost of Revenue | 17.00K | ||
| Gross Profit | 15.00K | ||
| Operating Expenses | 4.43M | ||
| Research and Development Expense | 4.95M | ||
| Selling, General and Administrative Expense | 5.39M | ||
| Operating Income | -4.41M | ||
| Interest Expense | 23.00K | ||
| Net Income | -4.29M | ||
| Net Income Common Stock | -4.29M | ||
| Net Income Common Stock (USD) | -4.29M | ||
| Consolidated Income | -4.29M | ||
| Earnings per Basic Share | -0.12 | ||
| Earnings per Basic Share (USD) | -0.12 | ||
| Earnings per Diluted Share | -0.12 | ||
| Earning Before Interest & Taxes (EBIT) | -4.27M | ||
| Earning Before Interest & Taxes (USD) | -4.27M | ||
| Weighted Average Shares | 34.52M | ||
| Weighted Average Shares Diluted | 34.52M | ||
| Balance Sheet | |||
| Cash and Equivalents | 28.93M | ||
| Cash and Equivalents (USD) | 28.93M | ||
| Trade and Non-Trade Receivables | 157.00K | ||
| Current Assets | 30.52M | ||
| Property, Plant & Equipment Net | 8.91M | ||
| Total Assets | 40.43M | ||
| Debt Current | 1.76M | ||
| Total Debt | 3.07M | ||
| Current Liabilities | 12.01M | ||
| Debt Non-Current | 1.31M | ||
| Total Liabilities | 51.12M | ||
| Accumulated Retained Earnings (Deficit) | -405.05M | ||
| Accumulated Other Comprehensive Income | 71.00K | ||
| Shareholders Equity | -10.69M | ||
| Shareholders Equity (USD) | -10.69M | ||
| Assets Non-Current | 9.91M | ||
| Total Debt (USD) | 3.07M | ||
| Inventory | 382.00K | ||
| Liabilities Non-Current | 39.11M | ||
| Trade and Non-Trade Payables | 4.35M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 631.00K | ||
| Net Cash Flow from Financing | 24.70M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 16.44M | ||
| Capital Expenditure | -613.00K | ||
| Issuance (Purchase) of Equity Shares | 26.02M | ||
| Issuance (Repayment) of Debt Securities | -143.00K | ||
| Net Cash Flow from Investing | -613.00K | ||
| Net Cash Flow from Operations | -7.64M | ||
| Effect of Exchange Rate Changes on Cash | -10.00K | ||
| Share Based Compensation | 647.00K | ||